Is Biocon good Share to buy?
ICICI Direct has buy call on Biocon with a target price of Rs 390. The current market price of Biocon Ltd. is Rs 332.9. Time period given by analyst is one year when Biocon Ltd.
Will Biocon share price go up?
Based on our forecasts, a long-term increase is expected, the “BIOCON” stock price prognosis for 2027-07-12 is 456.851 INR. With a 5-year investment, the revenue is expected to be around +37.48%. Your current $100 investment may be up to $137.48 in 2027.
Why Biocon shares are falling?
Biocon shares fall as rising raw material and logistics costs impact earnings.
Is Biocon a good company Quora?
Biocon is one of the top performer in Pharma space. It is trading at premium always because of its good quality management and business performance. Long term investors always like this as it has given good returns over a period of time. This has given about 300% returns in 5 years time.
How good is Biocon?
Biocon Biologics India is rated 4.0 out of 5, based on 1.6k reviews by employees on AmbitionBox. Biocon Biologics India is known for Job Security which is rated at the top and given a rating of 3.9. However, Salary & Benefits is rated the lowest at 3.5 and can be improved.
What is a stop loss order?
A stop order, also referred to as a stop-loss order, is an order to buy or sell a stock once the price of the stock reaches a specified price, known as the stop price. When the stop price is reached, a stop order becomes a market order. A buy stop order is entered at a stop price above the current market price.
Is Biocon a good company?
Is Biocon a good company to work for? Biocon has an overall rating of 3.8 out of 5, based on over 900 reviews left anonymously by employees. 77% of employees would recommend working at Biocon to a friend and 72% have a positive outlook for the business. This rating has improved by 1% over the last 12 months.
How much was the shares capital of Biocon at the time of establishment?
Biocon was founded in 1978 with Rs. 10,000 as the initial capital.
What are the future plans of Biocon?
Biocon unit plans 15% stake sale to Serum Institute for access to vaccines. The deal with Serum Institute Life Sciences values Biocon Biologics at about $4.9 billion and will solely focus on COVID-19 vaccines in the initial years, the companies said.
What is the rank of Biocon in India?
Biocon was ahead of leading global pharma companies like Novo Nordisk, Roche, Eli Lilly, Abbott, Novartis, Pfizer etc. in the 2020 rankings….Biocon Ranked Among Top 5 Biotech Employers Globally.
| 2020 Rank | 2019 Rank | Employer (Global HQ) |
|---|---|---|
| 3 | 1 | Alnylam Pharmaceuticals (Cambridge, MA) |
| 4 | 10 | Syngenta (Basel, Switzerland) |
| 5 | 6 | Biocon Limited (Bangalore, India) |
Why should I join Biocon?
1. Why should I choose Biocon? Working with one of the world’s most advanced biopharmaceutical companies brings with it a tremendous opportunity to create a lasting impact on global health. Our strategy is to provide affordable access to a speciality portfolio of medicines for global patient populations.
Why is Biocon successful?
Biocon is a leading company in making breakthroughs in clinical research. She is also the former chairperson of the Indian Institute of Management in Bangalore. As of January 2020, Kiran Mazumdar’s Net worth is $1.3 billion ….Biocon Chairperson Kiran Mazumdar Success Story.
| Details | Description |
|---|---|
| Occupation | Founder & chairperson of Biocon |
| Net Worth | $1.3 Billion |
What is the best way for Biocon India Group to expand?
- DEVELOP NEW FORMULATIONS AND PARTNER WITH GLOBAL PHARMACEUTICAL COMPANY TO GAIN KNOW-HOW TO START A NEW PRODUCT LINE .
- SPECIALISE AND DEVELOP CAPABILITIES OF R&D , WITH DISRUPTIVE AND ACTIVE INTENTION OF BECOMING MARKET LEADER .
- INNOVATE AND DEVELOP NEW MARKETING METHODS AND PROCEDURES .